Dan Auclair
@auclairdan.bsky.social
Blood cancer translational scientist with a special love for #myeloma, animals and nature friend | Opinions are my own #MyelomaSky #HemeSky
oncodaily.com/voices/danie... #Hemesky #myelomasky @oncodaily.bsky.social
Daniel Auclair: Annual ASCO26 List of 10 Interesting Myeloma Abstracts - OncoDaily
Daniel Auclair: Annual ASCO26 List of 10 Interesting Myeloma Abstracts / ASCO26, cancer, Daniel Auclair, Myeloma, OncoDaily, Oncology
oncodaily.com
PRDM1 shapes germinal center B-cell clonal diversity by gating chromatin accessibility during light-to-dark zone transition @biorxivpreprint.bsky.social www.biorxiv.org/content/10.1...
#IMS25 full abstracts are out! #myelomasky #hemesky
Hematocure@hematocure.bsky.social · 12mo agoThe full abstracts selected for #IMS25 have just been released! conferenceabstracts.com/uploads/docume… We are eagerly anticipating the great science to be showcased in Toronto in three weeks. Hematocure will attend, provide updates, and looks forward to reconnecting with colleagues. #mmsm
For breaking news and expert analysis during #ASCO25, turn to #ASCODailyNews! During and after the Meeting, ASCO Daily News has coverage of all the practice-changing research being presented. Bookmark us now: dailynews.ascopubs.org/meetings/asc... #oncsky
Now that the final #ASCO25 abstracts are out, here are my top #myelomasky ones Etentamig meetings.asco.org/abstracts-pr... IberVd meetings.asco.org/abstracts-pr... 5-Year Follow-up on CARTITUDE-1 meetings.asco.org/abstracts-pr...
The US has world-class scientific talent. The rest of the world is hoping to lure that away www.yahoo.com/news/us-worl...
The US has world-class scientific talent. The rest of the world is hoping to lure that away
As the Trump administration cut billions of dollars in federal funding to scientific research, thousands of scientists in the U.S. lost their jobs or grants — and governments and universities around t...
yahoo.com
Roche taps Broad Institute to test SBX sequencing in the clinic www.fiercebiotech.com/medtech/roch...
Roche taps Broad Institute to test SBX sequencing in the clinic
Roche raised the curtain on its novel approach to DNA sequencing earlier this year, and now it's working with the Broad Institute to explore its use cases, ahead of a full public launch s | Roche tapp...
fiercebiotech.com
An ultrasensitive method gor detection of cell-free RNA www.nature.com/articles/s41...
An ultrasensitive method for detection of cell-free RNA - Nature
A method, RARE-seq, for sensitive detection of cell-free RNAs in blood is demonstrated to have diverse clinical applications including diagnosing and characterizing human cancers, and tracking respons...
nature.com
Challenging times. Harvard at risk of losing $9 billion in federal funds as US launches review www.reuters.com/world/us/us-...
US reviewing federal contracts, grants to Harvard over antisemitism allegations
The administration of Republican President Donald Trump announced a review on Monday of federal contracts and grants at Harvard University over allegations of antisemitism.
reuters.com
Check out our #50ScientistsThatInspire interviews with Drs. Madhukar Pai, Johanna Joyce, Juan-Pablo Correa-Baena, & Hanna Kokko threaded below🧵 @madhupai.bsky.social @johannajoyce.bsky.social @jpcorreabaena.bsky.social @kokkonut.bsky.social
Quite an essay on the basis of cancer entitled "The End of the Genetic Paradigm of Cancer" @plosbiology.org arguing against the primacy of somatic mutations (traditional model) and cells, invoking gene regulatory networks and tissue journals.plos.org/plosbiology/...
BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement #MyelomaSky ashpublications.org/bloodadvance...
Advantages of a NGS assay for detection of mutant NPM1 MRD in AML #HemeSky - Detection of mNPM1 MRD by NGS overcomes several limitations of RT-qPCR - Prognostic significance of mNPM1 MRD appears greatest in patients with AML with a concomitant FLT3-ITD ashpublications.org/bloodadvance...
Large-scale dependency and drug screens characterize the therapeutic vulnerabilities of Multiple Myeloma with 1q+ @ireneghobrial.bsky.social #MyelomaSky ashpublications.org/blood/articl...
Nice review: Hallmarks of AI contributions to precision oncology www.nature.com/articles/s43...
Hallmarks of artificial intelligence contributions to precision oncology - Nature Cancer
Ruppin and colleagues overview recent research on the use of AI frameworks in precision oncology, describe ten hallmarks of their contributions across cancer detection, therapy optimization and treatm...
nature.com
New SEC filings reveal potential further impact of federal cuts www.wired.com/story/trump-...
Trump's FDA Cuts Are Putting Drug Development at Risk
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk's cost-cutting measures could slow drug research and delay FDA approvals.
wired.com
Dissecting tumor cell programs through biology estimation in clinic single-cell transcriptomics www.nature.com/articles/s41...
Dissecting tumor cell programs through group biology estimation in clinical single-cell transcriptomics - Nature Communications
Existing methods for identifying differential gene expression signatures for clinical case/control analyses with high throughput sequencing data present various challenges. Here, the authors develop B...
nature.com
Francis Collins retires from NIH www.npr.org/sections/sho...
Legendary former NIH director retires from embattled agency
Dr. Francis Collins is leaving the National Institutes of Health, where he served as director from 2009 to 2021. The agency is facing cutbacks and restrictions under the Trump administration.
npr.org
Lung-MAP 3.0. Adding NGS screening options for patient recruitment ascopost.com/issues/febru...
Lung-MAP 3.0: Simplifying the Process to Meet Patients’ Needs
The Lung Cancer Master Protocol (Lung-MAP) is an innovative clinical trial designed to efficiently address the unmet needs of patients with advanced non–small cell lung cancer (NSCLC) following front-...
ascopost.com
The time relegated to being data clerks among US physicians is increasing jamanetwork.com/journals/jam...
Trends in Physician Electronic Health Record Time and Message Volume
This cohort study uses national electronic health record data to assess patient medical advice request message volume and the time physicians spend in the records.
jamanetwork.com
Pitt to pause PhD admissions, following Vanderbilt and USC, because of uncertainty of NIH funding to academic universities. Who will teach and train US scientists for pharma and biotech? Should we import them from countries that do? www.wesa.fm/health-scien...
The University of Pittsburgh pauses its Ph.D. admissions process amid research funding uncertainty
A spokesperson for the University told WESA Friday that the school has "temporarily paused additional Ph.D. offers of admission," while Pitt works to understand how proposed federal funding cuts could...
wesa.fm
Turmoil at FDA and fears it might impact new drug approvals www.biospace.com/fda/fda-reel...
FDA Reels From ‘Indiscriminate’ Job Cuts Under Trump as Biopharma Appeals for Clarity
Morale is low at the FDA, which was hit with layoffs this week following RFK Jr.’s confirmation. Biopharma leaders and agency insiders fear further workforce cuts could delay new medicines.
biospace.com
Illumina unveils its novel spatial transcriptomics platform www.illumina.com/company/news...
Illumina unveils first-of-its-kind spatial transcriptomics technology
illumina.com
Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells #MyelomaSky ashpublications.org/bloodadvance...
Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells
Key PointsAblation of Blimp-1 in anti-BCMA CAR T cells improves efficacy, representing a promising novel therapeutic product for MM.Transcriptomic analysis
ashpublications.org
NIH reportedly loses two top leaders in two days www.qcnews.com/nexstar-medi...
NIH reportedly loses two top leaders in two days
Two key staff members at the National Institutes of Health (NIH) are reportedly leaving the agency amid ongoing efforts by the Trump administration and Department of Government Efficiency head Elon…
qcnews.com
Congrats, and happy to see your labor of love coming to fruitions Jonathan @pedalheadphx.bsky.social #MyelomaSky
Jonathan Keats, PhD 🇨🇦@pedalheadphx.bsky.social · 2y agoGreat meeting yesterday with the @cityofhope.bsky.social and @tgenresearch.bsky.social myeloma team working to bring rapid whole genome sequencing to myeloma patients. Special thanks to Suzie Nason helping make this dream a reality.
go.bsky.app/BtBs6xj Still slowly building a myeloma research oriented starter pack, let me know if you are missing.
